Newsroom

Newsroom

In the Spotlight

Company Update, April 26, 2022

Temedica wins further renowned industry representatives for expert advisory board

Munich, 26.04.2022 – Temedica GmbH, a leading digital health and health insights company, announced today the expansion of its expert advisory board, with three high-profile members from the fields of drug regulatory affairs, the pharmaceutical industry and real-world evidence.

Company Update, March 15, 2022

Temedica announces cooperation with Bristol Myers Squibb for the development of a digital companion for psoriasis patients

Munich, Germany, March 15, 2022 – Temedica GmbH, a leading digital health and health insights company, today announced its cooperation with Bristol Myers Squibb to develop a digital companion for patients with psoriasis.

Company Update, February 1, 2022

Temedica partners with NOVENTI to enhance Permea- generated insights to improve patient care

Munich, Germany, February 01, 2022 – Temedica GmbH, a leading digital health and health insights company, today announced its collaboration with NOVENTI Health SE, the largest provider of enterprise resource planning (ERP) systems and claims management solutions for pharmacies in Germany.

Press Contact